A majority think President Trump is failing to lower prescription drug prices as promised, according to a new survey, indicating that he may be at a disadvantage on one of the most sensitive election issues.
Trump’s approval rating for his efforts to lower prescription drug prices fell to 30%, with 54% disapproving, according to new Kaiser Family Foundation polling.
The new polling numbers come on the heels of reports that the president lashed out at Health and Human Services Secretary Alex Azar earlier this month for neglecting to come up with a plan to lower drug prices.
Trump told Azar over the phone that he was “not getting it done” and needed to “hurry up” on enacting measures to lower drug prices.
Lowering drug prices has been a key part of Trump’s healthcare agenda, but major changes have proved elusive. Various pieces of legislation to address high drug prices stalled in Congress in late 2019.
In December, Trump moved forward with a plan to initiate drug importation programs in an effort to bring less expensive prescriptions to the United States from Canada.
Trump’s approval ratings on healthcare issues fall along party lines, with Republicans giving him a 44 percentage point net approval rating on lowering drug prices.
